Barriers of Thrombolysis Therapy in Developing Countries

Thrombolysis in Stroke Patients; Problems and Limitations

Thrombolysis for stroke is being used in some developing countries. This study was designed to evaluate the problems of thrombolysis therapy in Iran. During January-July 2008, all patients with ischemic stroke admitted to Ghaem Hospital, Mashhad, northeast Iran, were enrolled in a prospective observational study. Ghaem Hospital is a tertiary care hospital that includes infrastructure for thromb...

After introduction of advanced therapeutic medicinal products (ATMPs) in Ischemic Stroke; novel therapeutic modalities from financial perspective

Stroke, is accounting for more than 34% of total healthcare spending globally. Ischemic stroke (IS) accounts for 62.4% of incident stroke cases. IS-related direct medical expenditures place a considerable burden on healthcare system. The burden is more prominent in developing countries where limitations in insurance coverage is a big concern. It would be less challenging in developed countries,...

Institutional Barriers to the Application of Urban Village as a Tool for Achieving Urban Sustainability in Developing Countries - the Case of Asheghabaad, Isfahan, Iran.

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation

BACKGROUND Intravenous thrombolysis is an approved treatment method for patients with acute ischemic stroke (AIS) and is recommended by multiple guidelines. However, it seems that it is less frequently used in the developing countries compared to the developed countries. OBJECTIVES The purpose of this study was to estimate the percentage of patients with AIS, eligible for intravenous thrombol...

Changing the Insight of Scientists in High Income Countries: A Solution for Collaborative Research with Lower Income Countries

The recent issue of Asia Pacific Journal of Medical Toxicology made an important and interesting theme “What is the Best Research for Low Income Countries?” (1). We enjoyed reading the paper; nevertheless we hope to find a chance to share our idea. It was mentioned that some, for sure not all, researchers from the developed countries might not have enough motivation to contribute to the scient...